Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.
Checked against the public recordLast updated Nov 19, 2018 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Other
- Study type
- Interventional
- Phase
- Not applicable
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Interventions being studied
- Other: SMS/MMS text messaging; Other: usual care
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK. * Starting a new treatment regimen that includes a single oral anticancer medication * Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled. * Age 18 or older. * Ability to speak and read English because we do not have the resources to translate the text messages into other languages. Exclusion Criteria: * Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Memorial Sloan Kettering Cancer CenterNew York, New York
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Nov 19, 2018. Always confirm current availability with the study team.